BioMarin Pharmaceutical Inc. (BMRN) was a big mover last session, as its shares rose a little over 8% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the uptrend for the company since Oct 15, as the stock is now up over 20%.
In the last 7 days, the company witnessed one positive estimate revision and the Zacks Consensus Estimate also moved higher, suggesting more solid trading ahead. So make sure to keep an eye on this stock going forward to see if Friday’s jump can turn into more strength down the road.
BioMarin Pharmaceutical currently has a Zacks Rank #3 (Hold) while its Earnings ESP is negative.
Other better-ranked biomedical stocks include Medivation, Inc. (MDVN), Merrimack Pharmaceuticals, Inc. (MACK) and Illumina Inc. (ILMN). All three sport a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
To read this article on Zacks.com click here.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
Be the first to comment